104 related articles for article (PubMed ID: 38795687)
1. Integrative analysis of systemic lupus erythematosus biomarkers: Role of fecal hsa-mir-223-3p and gut microbiota in transkingdom dynamics.
Quesada S; Rosso AD; Mascardi F; Soler-Rivero V; Aguilera P; Mascuka SN; Boiro A; Arenielo E; Vijoditz G; Ferreyra-Mufarregue LR; Caputo MF; Cimolai MC; Coluccio Leskow F; Penas-Steinhardt A; Belforte FS
Mol Immunol; 2024 Jul; 171():77-92. PubMed ID: 38795687
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus.
Ma Y; Xu X; Li M; Cai J; Wei Q; Niu H
Mol Med; 2019 Aug; 25(1):35. PubMed ID: 31370803
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients.
Li XB; Chu XJ; Cao NW; Wang H; Fang XY; Fan YG; Li BZ; Ye DQ
BMC Microbiol; 2022 Apr; 22(1):117. PubMed ID: 35477382
[TBL] [Abstract][Full Text] [Related]
4. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus.
Li Y; Wang HF; Li X; Li HX; Zhang Q; Zhou HW; He Y; Li P; Fu C; Zhang XH; Qiu YR; Li JL
Clin Sci (Lond); 2019 Apr; 133(7):821-838. PubMed ID: 30872359
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention.
Zhang L; Qing P; Yang H; Wu Y; Liu Y; Luo Y
Front Immunol; 2021; 12():686501. PubMed ID: 34335588
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus.
Luo XM; Edwards MR; Mu Q; Yu Y; Vieson MD; Reilly CM; Ahmed SA; Bankole AA
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29196292
[TBL] [Abstract][Full Text] [Related]
7. Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus.
Kim BS; Jung JY; Jeon JY; Kim HA; Suh CH
HLA; 2016 Oct; 88(4):187-93. PubMed ID: 27596248
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies.
Pan Q; Guo F; Huang Y; Li A; Chen S; Chen J; Liu HF; Pan Q
Front Immunol; 2021; 12():799788. PubMed ID: 34925385
[TBL] [Abstract][Full Text] [Related]
9. An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus.
Chen BD; Jia XM; Xu JY; Zhao LD; Ji JY; Wu BX; Ma Y; Li H; Zuo XX; Pan WY; Wang XH; Ye S; Tsokos GC; Wang J; Zhang X
Arthritis Rheumatol; 2021 Feb; 73(2):232-243. PubMed ID: 33124780
[TBL] [Abstract][Full Text] [Related]
10. Shared gut, but distinct oral microbiota composition in primary Sjögren's syndrome and systemic lupus erythematosus.
van der Meulen TA; Harmsen HJM; Vila AV; Kurilshikov A; Liefers SC; Zhernakova A; Fu J; Wijmenga C; Weersma RK; de Leeuw K; Bootsma H; Spijkervet FKL; Vissink A; Kroese FGM
J Autoimmun; 2019 Feb; 97():77-87. PubMed ID: 30416033
[TBL] [Abstract][Full Text] [Related]
11. Lupus gut microbiota transplants cause autoimmunity and inflammation.
Ma Y; Guo R; Sun Y; Li X; He L; Li Z; Silverman GJ; Chen G; Gao F; Yuan J; Wei Q; Li M; Lu L; Niu H
Clin Immunol; 2021 Dec; 233():108892. PubMed ID: 34813937
[TBL] [Abstract][Full Text] [Related]
12. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus.
Guo M; Wang H; Xu S; Zhuang Y; An J; Su C; Xia Y; Chen J; Xu ZZ; Liu Q; Wang J; Dan Z; Chen K; Luan X; Liu Z; Liu K; Zhang F; Xia Y; Liu X
Gut Microbes; 2020 Nov; 11(6):1758-1773. PubMed ID: 32507008
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial.
Huang C; Yi P; Zhu M; Zhou W; Zhang B; Yi X; Long H; Zhang G; Wu H; Tsokos GC; Zhao M; Lu Q
J Autoimmun; 2022 Jun; 130():102844. PubMed ID: 35690527
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of microRNA-762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus.
Yang J; Li C; Chi S; Wei H; Du W; Hu Q
Immun Inflamm Dis; 2022 Nov; 10(11):e719. PubMed ID: 36301034
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the fecal and vaginal microbiomes in patients with systemic lupus erythematosus and their associations with immunological profiles.
Ling Z; Cheng Y; Gao J; Lei W; Yan X; Hu X; Shao L; Liu X; Kang R
Front Immunol; 2023; 14():1135861. PubMed ID: 36969178
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery.
Toumi E; Goutorbe B; Plauzolles A; Bonnet M; Mezouar S; Militello M; Mege JL; Chiche L; Halfon P
Front Immunol; 2022; 13():943241. PubMed ID: 35983031
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of oral microbiota is associated with systemic lupus erythematosus.
Li BZ; Zhou HY; Guo B; Chen WJ; Tao JH; Cao NW; Chu XJ; Meng X
Arch Oral Biol; 2020 May; 113():104708. PubMed ID: 32203722
[TBL] [Abstract][Full Text] [Related]
18. Microbiome and Metabolome Analyses Reveal the Disruption of Lipid Metabolism in Systemic Lupus Erythematosus.
He J; Chan T; Hong X; Zheng F; Zhu C; Yin L; Dai W; Tang D; Liu D; Dai Y
Front Immunol; 2020; 11():1703. PubMed ID: 32849599
[TBL] [Abstract][Full Text] [Related]
19. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.
Ogunrinde E; Zhou Z; Luo Z; Alekseyenko A; Li QZ; Macedo D; Kamen DL; Oates JC; Gilkeson GS; Jiang W
Arthritis Rheumatol; 2019 Nov; 71(11):1858-1868. PubMed ID: 31106972
[TBL] [Abstract][Full Text] [Related]
20. Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese.
Tomofuji Y; Maeda Y; Oguro-Igashira E; Kishikawa T; Yamamoto K; Sonehara K; Motooka D; Matsumoto Y; Matsuoka H; Yoshimura M; Yagita M; Nii T; Ohshima S; Nakamura S; Inohara H; Takeda K; Kumanogoh A; Okada Y
Ann Rheum Dis; 2021 Dec; 80(12):1575-1583. PubMed ID: 34426398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
